According to a ranking by Statista and Newsweek, the best hospital in the United States is the Mayo Clinic in Rochester, Minnesota. Moreover, the Mayo Clinic was also ranked as the best hospital in the world, among over 50,000 hospitals in 30 countries. Cleveland Clinic in Ohio and the Johns Hopkins Hospital in Maryland were ranked as second and third best respectively in the U.S., while they were second and forth best respectively in the World.

According to a ranking of the best hospitals in the U.S., the best hospital for adult cancer is the University of Texas MD Anderson Cancer Center, which had a score of 100 out of 100, as of 2024. This statistic shows the top 10 hospitals for adult cancer in the United States based on the score given by U.S. News and World Report's annual hospital ranking.

According to a ranking by Statista and Newsweek, the best hospital in Sweden is the Karolinska Universitetssjukhuset in Stockholm. Moreover, Karolinska Universitetssjukhuset was also ranked as the seventh-best hospital in the world, among over 50,000 hospitals in 30 countries. Sahlgrenska Universitetssjukhuset in Göteborg and Akademiska Sjukhuset in Uppsala were ranked as second and third best respectively in the Sweden, while they were 74th and 75th best respectively in the World.

According to a ranking by Statista and Newsweek, the best hospital in Denmark is the Rigshospitalet - København in Copenhagen. Moreover, the Rigshospitalet - København was also ranked as the 21st best hospital in the world, among over 50,000 hospitals in 30 countries. Aarhus Universitetshospital in Aarhus and Odense Universitetshospital in Odense were ranked as second and third best respectively in the Denmark, while they were 23rd and 85th best respectively in the World.

According to a ranking by Statista and Newsweek, the best hospital in Norway is Oslo Universitetssykehus in Oslo. Moreover, Oslo Universitetssykehus was also ranked as the 29th best hospital in the world, among over 50,000 hospitals in 30 countries. St. Olavs Hospital in Trondheim and Haukeland Universitetssykehus in Bergen were ranked as second and third best respectively in the Norway, while they were 138th and 151st best respectively in the World.

South Korea Number of Hospital was up 3.5% in 2019, compared to the previous year.

According to a ranking by Statista and Newsweek, the best hospital in Finland is Helsinki University Hospital in Helsinki. Moreover, Helsinki University Hospital was also ranked as the 50th best hospital in the world, among over 50,000 hospitals in 30 countries. Tampere University Hospital in Tampere and Turku University Hospital in Turku were ranked as second and third best respectively in the Finland, while they were 126th and 121st best respectively in the World.

According to a ranking of the best hospitals in the U.S., the best hospital for adult cardiology, heart, and vascular surgery is the Cleveland Clinic in Ohio, which had a score of 100 out of 100, as of 2024. This statistic shows the top 10 hospitals for adult cardiology, heart, and vascular surgery in the United States based on the score given by U.S. News and World Report's annual hospital ranking.

Hospitals play a critical role in healthcare, offering specialized treatments and emergency services essential for public health, regardless of economic fluctuations or individuals' financial situations. Rising incomes and broader access to insurance have fueled demand for care in recent years, supporting hospitals' post-pandemic recovery initiated by federal policies and funding. The recovery for many hospitals was also promoted by mergers that lessened financial strains, especially in rural hospitals. This trend toward consolidation has resulted in fewer enterprises relative to establishments, enhancing hospitals' bargaining power regarding input costs and insurance reimbursements. With this improved position, hospitals are expected to see revenue climb at a CAGR of 2.0%, reaching $1.5 trillion by 2025, with a 3.2% increase in 2025 alone. Competition, economic conditions and regulatory changes will impact hospitals based on size and location. Smaller hospitals, particularly rural ones, may encounter more significant obstacles as the industry transitions from fee-based to value-based care. Independent hospitals face wage inflation, staffing shortages and drug supply costs. Although state and federal policies aim to support small rural hospitals in addressing hospital deserts, uncertainties linger over federal Medicare funding and Medicaid reimbursements, which account for nearly half of hospital care spending. Even so, increasing per capita disposable income and increasing the number of individuals with private insurance will boost revenues from private insurers and out-of-pocket payments for all hospitals, big and small. Hospitals will continue incorporating technological advancements in AI, telemedicine and wearables to enhance their services and reduce cost. These technologies aid hospital systems in strategically expanding outpatient services, mitigating the increasing competitive pressures from Ambulatory Surgery Centers (ASCs) and capitalizing on the increased needs of an aging adult population and shifts in healthcare delivery preferences. As the consolidation trend advances and technology adoption further leverages economies of scale, industry revenue is expected to strengthen at a CAGR of 2.4%, reaching $1.7 trillion by 2030, with steady profit over the period.

In 2023, there were nearly 11 thousand hospitals in Columbia, the highest number among OECD countries, followed by 8,156 hospitals in Japan. If only general hospitals were counted (excluding mental health hospitals and other specialized hospitals), Japan had the most number of general hospitals among OECD countries worldwide. Most countries reported hospitals numbers similar to or lower than the previous year. Meanwhile, Mexico, South Korea and the Netherlands all reported more hospitals than last year.

The global Top 10 Medical Device Technologies Market size is projected to grow USD 708.79 billion by 2030, at a CAGR of 6.71% by 2030

In 2023, Singapore dominated the ranking of the world's health and health systems, followed by Japan and South Korea. The health index score is calculated by evaluating various indicators that assess the health of the population, and access to the services required to sustain good health, including health outcomes, health systems, sickness and risk factors, and mortality rates. The health and health system index score of the top ten countries with the best healthcare system in the world ranged between 82 and 86.9, measured on a scale of zero to 100.

Global Health Security Index  Numerous health and health system indexes have been developed to assess various attributes and aspects of a nation's healthcare system. One such measure is the Global Health Security (GHS) index. This index evaluates the ability of 195 nations to identify, assess, and mitigate biological hazards in addition to political and socioeconomic concerns, the quality of their healthcare systems, and their compliance with international finance and standards. In 2021, the United States was ranked at the top of the GHS index, but due to multiple reasons, the U.S. government failed to effectively manage the COVID-19 pandemic. The GHS Index evaluates capability and identifies preparation gaps; nevertheless, it cannot predict a nation's resource allocation in case of a public health emergency.

Universal Health Coverage Index  Another health index that is used globally by the members of the United Nations (UN) is the universal health care (UHC) service coverage index. The UHC index monitors the country's progress related to the sustainable developmental goal (SDG) number three. The UHC service coverage index tracks 14 indicators related to reproductive, maternal, newborn, and child health, infectious diseases, non-communicable diseases, service capacity, and access to care. The main target of universal health coverage is to ensure that no one is denied access to essential medical services due to financial hardships. In 2021, the UHC index scores ranged from as low as 21 to a high score of 91 across 194 countries. 

According to cognitive market research-"Global Medical Disposables market size 2023 was XX Million. Medical Disposables Industry compound annual growth rate (CAGR) will be XX% from 2024 till 2031."

  In 2023, the sterilisation supplies segment held the lead with XX% of total revenue. Infection control is critical in healthcare settings.
  The plastic resin segment dominated the market in 2023. Infection control is critical in healthcare settings.
  Hospitals dominated the market in 2023 because they provide a diverse range of medical services and treatments, including various medical specialties and procedures.
  North America accounted for XX% of the worldwide market in 2023 and is expected to maintain its dominance during the forecast period. North America boasts a highly developed and modern healthcare infrastructure, including hospitals, clinics, and medical facilities.

Current scenario of the Medical disposables market

Key drivers of the Medical Disposables market

An increase in hospital-acquired infections (HAIs) around the globe is fuelling market demand. 

HAI is becoming an increasingly serious issue in healthcare facilities around the world. According to the WHO, 10 out of every 100 hospital patients in developing countries and seven in industrialised nations suffer from HAIs. Infectious agents provide an elevated risk to health practitioners and professionals, and patients who are exposed are more likely to catch hospital-acquired diseases. According to statistical research published by the Centers for Disease Control and Prevention (CDC), such HAIs cause around 1.7 million diseases and more than 99,000 deaths in American hospitals. https://www.who.int/news/item/06-05-2022-who-launches-first-ever-global-report-on-infection-prevention-and-control#:~:text=Today%2C%20out%20of%20every%20100,will%20die%20from%20their%20HAI.

HAIs were listed among the top five leading causes of mortality. Surgical infections, urinary tract infections, lung infections, and bloodstream infections are some of the most common hospital-acquired infection types. According to the American Hospital Association, post-surgical bloodstream infections have grown by 8%, while urinary tract infections have increased by 3.6% as a result of catheter placement during surgery. As a result, the usage of medical disposables may play an important role in preventing cross-contamination and reducing the danger of infection spread, driving the market to higher standards. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501203/

Rising Diabetes Rates Will Drive Up market demand

Rapid urbanization and the growing trend towards sedentary lifestyles in both developed and emerging nations are the main causes of the increased prevalence of diabetes. According to the International Diabetes Federation, 537 million adults globally were predicted to have diabetes in 2021; 51.6% of those people were estimated to reside in China, India, the United States, Brazil, and Mexico. The rapid acceptance of these systems worldwide can be attributed to the large rise in the number of patients with type-1 or insulin-dependent type 2 diabetes. Type 1 diabetes affects around 149.5 out of every 1,000 children and teenagers worldwide, accounting for 9.8% of the total population. https://idf.org/about-diabetes/diabetes-facts-figures/ Long-term diabetes may result in foot ulcers, longer hospital stays, and a positive impact on the market during the forecast period. Despite the healthcare industry's careful efforts, many people contract hospital-acquired infections while being treated there. The Centres for Disease Control and Prevention (CDC) estimate that over 3% of patients in the United States contract hospital-acquired infections each year.

Constraints for the global Medical Disposables market

The increase in waste production limits market expansion.

The sustainable healthcare business requires effective biomedical waste management. Efficiency in processing the vast amount of generated biomedical waste became a work for the entire world, as well as a fight to manage the exuberant amount of garbage, with the outbreak of the COVID-19 pandemic, when hospitals and care centres were inundated with patients. Despite the fact that the bulk of medical waste poses no harm to...

Updates

• Notice of data discontinuation: Since the start of the pandemic, AP has reported case and death counts from data provided by Johns Hopkins University. Johns Hopkins University has announced that they will stop their daily data collection efforts after March 10. As Johns Hopkins stops providing data, the AP will also stop collecting daily numbers for COVID cases and deaths. The HHS and CDC now collect and visualize key metrics for the pandemic. AP advises using those resources when reporting on the pandemic going forward.

  • CDC Weekly case and death counts (national and state level)
  • CDC County level cases and deaths
  • HHS New hospital admissions
  • CDC NowCast COVID variant proportions (national and regional level)

• April 9, 2020

  • The population estimate data for New York County, NY has been updated to include all five New York City counties (Kings County, Queens County, Bronx County, Richmond County and New York County). This has been done to match the Johns Hopkins COVID-19 data, which aggregates counts for the five New York City counties to New York County.

• April 20, 2020

  • Johns Hopkins death totals in the US now include confirmed and probable deaths in accordance with CDC guidelines as of April 14. One significant result of this change was an increase of more than 3,700 deaths in the New York City count. This change will likely result in increases for death counts elsewhere as well. The AP does not alter the Johns Hopkins source data, so probable deaths are included in this dataset as well.

• April 29, 2020

  • The AP is now providing timeseries data for counts of COVID-19 cases and deaths. The raw counts are provided here unaltered, along with a population column with Census ACS-5 estimates and calculated daily case and death rates per 100,000 people. Please read the updated caveats section for more information.

• September 1st, 2020

  • Johns Hopkins is now providing counts for the five New York City counties individually.

• February 12, 2021

  • The Ohio Department of Health recently announced that as many as 4,000 COVID-19 deaths may have been underreported through the state’s reporting system, and that the "daily reported death counts will be high for a two to three-day period."
  • Because deaths data will be anomalous for consecutive days, we have chosen to freeze Ohio's rolling average for daily deaths at the last valid measure until Johns Hopkins is able to back-distribute the data. The raw daily death counts, as reported by Johns Hopkins and including the backlogged death data, will still be present in the new_deaths column.

• February 16, 2021

  - Johns Hopkins has reconciled Ohio's historical deaths data with the state.

  Overview

The AP is using data collected by the Johns Hopkins University Center for Systems Science and Engineering as our source for outbreak caseloads and death counts for the United States and globally.

The Hopkins data is available at the county level in the United States. The AP has paired this data with population figures and county rural/urban designations, and has calculated caseload and death rates per 100,000 people. Be aware that caseloads may reflect the availability of tests -- and the ability to turn around test results quickly -- rather than actual disease spread or true infection rates.

This data is from the Hopkins dashboard that is updated regularly throughout the day. Like all organizations dealing with data, Hopkins is constantly refining and cleaning up their feed, so there may be brief moments where data does not appear correctly. At this link, you’ll find the Hopkins daily data reports, and a clean version of their feed.

The AP is updating this dataset hourly at 45 minutes past the hour.

To learn more about AP's data journalism capabilities for publishers, corporations and financial institutions, go here or email kromano@ap.org.

Queries

Use AP's queries to filter the data or to join to other datasets we've made available to help cover the coronavirus pandemic

• Filter cases by state here

• Rank states by their status as current hotspots. Calculates the 7-day rolling average of new cases per capita in each state: https://data.world/associatedpress/johns-hopkins-coronavirus-case-tracker/workspace/query?queryid=481e82a4-1b2f-41c2-9ea1-d91aa4b3b1ac

• Find recent hotspots within your state by running a query to calculate the 7-day rolling average of new cases by capita in each county: https://data.world/associatedpress/johns-hopkins-coronavirus-case-tracker/workspace/query?queryid=b566f1db-3231-40fe-8099-311909b7b687&showTemplatePreview=true

• Join county-level case data to an earlier dataset released by AP on local hospital capacity here. To find out more about the hospital capacity dataset, see the full details.

• Pull the 100 counties with the highest per-capita confirmed cases here

• Rank all the counties by the highest per-capita rate of new cases in the past 7 days here. Be aware that because this ranks per-capita caseloads, very small counties may rise to the very top, so take into account raw caseload figures as well.

Interactive

The AP has designed an interactive map to track COVID-19 cases reported by Johns Hopkins.

@(https://datawrapper.dwcdn.net/nRyaf/15/)

Interactive Embed Code

<iframe title="USA counties (2018) choropleth map Mapping COVID-19 cases by county" aria-describedby="" id="datawrapper-chart-nRyaf" src="https://datawrapper.dwcdn.net/nRyaf/10/" scrolling="no" frameborder="0" style="width: 0; min-width: 100% !important;" height="400"></iframe><script type="text/javascript">(function() {'use strict';window.addEventListener('message', function(event) {if (typeof event.data['datawrapper-height'] !== 'undefined') {for (var chartId in event.data['datawrapper-height']) {var iframe = document.getElementById('datawrapper-chart-' + chartId) || document.querySelector("iframe[src*='" + chartId + "']");if (!iframe) {continue;}iframe.style.height = event.data['datawrapper-height'][chartId] + 'px';}}});})();</script>

Caveats

• This data represents the number of cases and deaths reported by each state and has been collected by Johns Hopkins from a number of sources cited on their website.
• In some cases, deaths or cases of people who've crossed state lines -- either to receive treatment or because they became sick and couldn't return home while traveling -- are reported in a state they aren't currently in, because of state reporting rules.
• In some states, there are a number of cases not assigned to a specific county -- for those cases, the county name is "unassigned to a single county"
• This data should be credited to Johns Hopkins University's COVID-19 tracking project. The AP is simply making it available here for ease of use for reporters and members.
• Caseloads may reflect the availability of tests -- and the ability to turn around test results quickly -- rather than actual disease spread or true infection rates.
• Population estimates at the county level are drawn from 2014-18 5-year estimates from the American Community Survey.
• The Urban/Rural classification scheme is from the Center for Disease Control and Preventions's National Center for Health Statistics. It puts each county into one of six categories -- from Large Central Metro to Non-Core -- according to population and other characteristics. More details about the classifications can be found here.

Johns Hopkins timeseries data - Johns Hopkins pulls data regularly to update their dashboard. Once a day, around 8pm EDT, Johns Hopkins adds the counts for all areas they cover to the timeseries file. These counts are snapshots of the latest cumulative counts provided by the source on that day. This can lead to inconsistencies if a source updates their historical data for accuracy, either increasing or decreasing the latest cumulative count. - Johns Hopkins periodically edits their historical timeseries data for accuracy. They provide a file documenting all errors in their timeseries files that they have identified and fixed here

Attribution

This data should be credited to Johns Hopkins University COVID-19 tracking project

According to a hospital ranking carried out in 2022 and based on seven different dimensions, Hospital Israelita Albert Einstein was considered the hospital with the highest care quality in Latin America. Located in São Paulo - Brazil, this health institution reached a quality index score of 93.46. Hospital Sírio-Libanês also located in Brazil, ranked second, with a score of 71.75. Latin American hospitals and their capacity to host patients When it comes to hosting patients, hospitals Irmandade da Santa Casa de Misericórdia de Porto Alegre located in Brazil, and Sanatorio Guemes based in Argentina, ranked among the leading hospitals in Latin America as of 2022. It was estimated that Brazil and Argentina were the two Latin American countries with the highest number of hospital beds in the region in 2020, with more than 448,000 and 234,000 hospital beds, respectively. Public opinion on healthcare quality It was also Argentina that had the highest share of satisfied patients among a selection of countries in Latin America according to a 2023 survey, with 50 percent of interviewees stating they had accessed a good or very good healthcare service. Colombian patients followed, with four out of ten people satisfied with the healthcare received. Accordingly, a recent study estimated that nearly half of the population in Argentina and Colombia distrusted the healthcare system, with approximately 47 percent and 50 percent of respondents claiming they trust the health systems in their respective countries.

As of 2022, the largest hospital in the world was found in Henan, China. With seven thousand beds, First Affiliated Hospital of Zhengzhou University was ranked as the largest hospital globally according to its number of beds. The second largest hospital was also found in China. No U.S. hospital made the world top 20 list, although AdventHealth Orlando was close, being the largest hospital in the United States.

Snapshot img { margin: 10px !important; } This market research report presents a detailed segmentation of the global blood pressure monitoring testing market by product (sphygmomanometers, automated and ambulatory blood pressure monitors, blood pressure transducers, and blood pressure monitor consumables), by end users (large hospitals, mid-sized hospitals, and other settings), and by geography (the Americas, APAC, and EMEA). The leading vendors in this market are A&D Medical, GE, Omron, Philips, SunTech Medical, and Welch Allyn.

Blood Pressure Monitoring Testing Market insights

According to the blood pressure monitoring testing industry analysis, Technavio’s market research analyst predicts that the global blood pressure (BP) monitoring testing market will grow at a significant CAGR of over 7% during the forecast period. One of the primary drivers for this market is the rising preference of consumers for home healthcare monitoring. Recently, it has been observed that many people have started to suffer from chronic hypertension, which can be controlled with the help of drugs and a regulated lifestyle. People now prefer home healthcare to reduce hospital stays and associated costs. Consequently, most people have started using digital, portable, and easy-to-use blood pressure monitors as they can be used at home and are highly accurate. This recent increase in the number of people opting for portable devices to manage their condition better will lead to the growth of this market during the predicted period.

In this industry report, the analysts estimate factors like the increasing focus on preventive treatment to play a vital role in the adoption of BP monitoring devices during the estimated period. Hospitals and healthcare centers like other businesses have to lower their expenses without compromising on the quality of care. People with cardiovascular disorders can get diagnosed early and implement preventive treatment methods prescribed by healthcare providers. Based on the blood pressure monitoring testing market trends, BP monitors are reliable tools as they offer accurate results and are easy to use. The increased adoption of BP monitors and a focus on preventive care will boost growth in the global BP monitoring testing market until the end of 2020.

Product-based segmentation of the BP monitoring testing market

Sphygmomanometers
Automated and ambulatory blood pressure monitors
Blood pressure transducers
Blood pressure monitor consumables

The sphygmomanometers segment was the largest in the global BP monitoring testing market with a market share of close to 54% in 2015. Increased awareness about the importance of managing BP levels will drive the demand for sphygmomanometer in hospitals and other settings.

Geographical segmentation of the BP monitoring testing market

Americas
APAC
EMEA

The Americas dominated the global BP monitoring testing market in 2015 with a market share of over 43%. This area will experience significant growth due to an increase in obese and older populations who need treatment for cardiovascular problems. Technological advances and the easy availability of BP monitoring devices in this region have resulted in its increased acceptance and use by consumers.

Competitive landscape and key vendors

The global BP monitoring testing market is highly fragmented due to the presence of several vendors and some niche suppliers. The market is also characterized by the presence of well-diversified international and local suppliers, with the global vendors occupying a dominant position. Many vendors adopt product bundling strategies and offer a combination of two or more products/services to augment product sales. However, these companies are losing market shares to medium- and small-sized suppliers who compete with them on the basis of price. In this market, the level of competition will intensify with the introduction of technological innovations and product extensions.

Key vendors in the market are

A&D Medical
GE
Omron
Philips
SunTech Medical
Welch Allyn

Other vendors in the market include American Diagnostic, Beurer, Bosch + Sohn, Briggs Healthcare, ChoiceMMed, CITIZEN SYSTEMS JAPAN, CONTEC MEDICAL SYSTEMS, Erka, Geratherm Medial, HONSUN, Medtronic, Masimo, Microlife, Nihon Kohden, Norditalia Group, Riester, Rossmax International, Schiller, Shenzhen Mindray Bio-Medical Electronics, Spacelabs Healthcare, Suzuken, Truly Healthcare, Vasomedical, and Withings.

Key questions answered in the report include

What will the market size and the growth rate be in 2020?
What are the key factors driving the global BP monitoring testing market?
What are the key market trends influencing the growth of the global BP monitoring testing market?
What are the challenges to market growth?
Who are the key vendors in the global BP monitoring testing market?
What are the ma

The Global Medical Oxygen Cylinders Market Report is Segmented by Product Type (Portable and Heavy), Product Size (Less than 10 liter, 10 liter - 50 liter, and more than 50 liter), End User (Hospitals, Home Healthcare, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value in USD for the above segments.

Government Hospital: West Bengal: Number of Hospitals data was reported at 1,510.000 Unit in 2022. This records a decrease from the previous number of 1,594.000 Unit for 2019. Government Hospital: West Bengal: Number of Hospitals data is updated yearly, averaging 1,082.000 Unit from Dec 2005 (Median) to 2022, with 10 observations. The data reached an all-time high of 1,594.000 Unit in 2019 and a record low of 294.000 Unit in 2009. Government Hospital: West Bengal: Number of Hospitals data remains active status in CEIC and is reported by Central Bureau of Health Intelligence. The data is categorized under India Premium Database’s Health Sector – Table IN.HLA001: Health Infrastructure: Government Hospitals.

Snapshot img

Neuromuscular Disease Therapeutics Market Size 2025-2029

The neuromuscular disease therapeutics market size is forecast to increase by USD 13.73 billion at a CAGR of 14.6% between 2024 and 2029.

Neuromuscular diseases (NDMs) are a group of disorders that affect the nervous and muscular systems, leading to muscle weakness, wasting, and paralysis. The neuromuscular disease therapeutics market is experiencing significant growth due to several key factors. The approval of novel therapeutics for NDMs is increasing, providing new treatment options for patients. 
Technological advances in neuromuscular disease therapy, such as gene therapy and stem cell therapy, are revolutionizing the way these conditions are treated. However, the high cost of these therapies remains a significant challenge for patients, limiting access and affordability. Despite this, the market is expected to continue growing due to the unmet medical need and the potential of these innovative treatments to improve patient outcomes.

What will be the size of Market during the forecast period?

Request Free Neuromuscular Disease Therapeutics Market Sample

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.

End-user

  Hospitals
  Clinics
  Others


Type

  Biologics
  Small molecules


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France
    Italy


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

Which is the largest segment driving market growth?

The market share growth by the hospitals segment will be significant during the forecast period. The market is primarily driven by the large number of patients diagnosed with neuromuscular diseases, particularly in hospitals. Neuromuscular diseases, such as spinal muscular atrophy (SMA), are treated in hospitals using advanced therapies like gene therapy (Zolgensma) and drugs (nusinersen, Spinraza, and risdiplam, Evrysdi).

Get a glance at the market share of various regions. Download the PDF Sample

The hospitals segment was the largest and was valued at USD 4.17 billion in 2018. Hospitals accounted for the largest market share in 2024 due to the high volume of patients receiving treatment for neuromuscular diseases. The market is expected to continue its dominance during the forecast period as hospitals remain the primary setting for neuromuscular disease treatment and patient care. Neuromuscular diseases, which affect the neuromuscular junction, can lead to conditions like paralysis. Other therapeutic areas, such as oncology and cardiovascular disease, are also exploring neuromuscular disease therapeutics for their pipeline.

Which region is leading the market?

For more insights on the market share of various regions, Request Free Sample

North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional market trends and drivers that shape the market during the forecast period. The market in North America is experiencing significant growth due to the rising prevalence of neuromuscular diseases and the availability of advanced medical technologies for their treatment. For instance, spinal muscular atrophy, a common neuromuscular disease, affects approximately 10 to 16.66 out of every 100,000 newborns in the US, with 2.0%-2.5% of the total population being carriers of the disease gene. The high fatality rate of spinal muscular atrophy and the increasing demand for effective treatments have led to extensive research and development of gene therapies for its cure. Neuromuscular diseases, such as epilepsy and Multiple Sclerosis, significantly impact the quality of life of patients. The market is driven by the development of intravenous administration drugs and medical technologies to address the unmet medical needs of patients with these conditions.

How can Technavio assist you in making critical decisions?

What is the market structure and year-over-year growth of the Neuromuscular Disease Therapeutics Market?

    Market structure


    Fragmented




    YoY growth 2024-2025


    11.6

Market Dynamics

The market represents a significant and growing segment within the healthcare industry. This market encompasses various therapeutic modalities, including anesthesia drugs, medical devices, and healthcare technology, designed to address the unique challenges posed by neuromuscular disorders. Neuromuscular disorders, such as Parkinson's disease, Alzheimer's disease, and Huntington's disease, present complex clinical scenarios requiring innovative solutions. Anesthesia plays a crucial role in managin